Chronic myeloid leukemia patients resistant to or intolerant of interferon alpha and subsequently treated with imatinib show reduced immunoglobulin levels and hypogammaglobulinemia. (Q44511020)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Chronic myeloid leukemia patients resistant to or intolerant of interferon alpha and subsequently treated with imatinib show reduced immunoglobulin levels and hypogammaglobulinemia. |
scientific article |
Statements
Chronic myeloid leukemia patients resistant to or intolerant of interferon alpha and subsequently treated with imatinib show reduced immunoglobulin levels and hypogammaglobulinemia (English)
Juan Luis Steegmann
Gemma Moreno
Concepción Aláez
Santiago Osorio
Asunción Granda
Rafael de la Cámara
Eva Arranz
Fernando Gómez Reino
Francisco Rodriguez Salvanés
José María Fernández-Rañada
Cecilia Muñoz